HR Execs on the Move


 
AstraZeneca is a global, science-led biopharmaceutical company that spans the discovery, development, manufacturing, distribution and worldwide commercialisation of primary care and speciality care medicines. We believe the best way we can help patients is to focus on breakthrough science in order to uncover disease mechanisms and develop novel, targeted therapies that interact with them. This is at the heart of our purpose as a company: to push the boundaries of science to deliver life-changing medicines. We invest in distinctive science in three main therapy areas where we believe we can make the most meaningful difference to patients: oncology; cardiovascular and metabolic diseases; ...
  • Number of Employees: 5K-10K
  • Annual Revenue: > $1 Billion

Executives

Name Title Contact Details
Candis Fields-Johnson
Head of Learning and Development and Global Operations Profile
Sendhil Kumaran
Senior Global Clinical Operations Program Director , Oncology R&D Profile
Carlos Rodriguez-Garcia
Director of Operations Support at AstraZeneca Lokelma Supply Site Profile
Gena Restivo
Vice President of Human Resources and Communications Profile
Liz Moran
Senior Director of Talent, Development and Performance Profile

Similar Companies

Adamas Pharmaceuticals, Inc.

Adamas Pharmaceuticals, Inc. is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Emeryville, CA. To find more information about Adamas Pharmaceuticals, Inc., please visit www.adamaspharma.com

Care Net

Care Net is a Birmingham, AL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

China Aoxing Pharmaceutical Company

China Aoxing Pharmaceutical Company is a Jersey City, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Meadow Glen Of Leesburg

Meadow Glen Of Leesburg is a Leesburg, VA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Menlo Therapeutics

We are a late stage biopharmaceutical company focused on the development and commercialization of serlopitant for the treatment of pruritus, or itch, associated with various conditions. We believe that serlopitant, a highly selective small molecule inhibitor of the neurokinin 1 receptor, or NK1R, given as a once daily, oral tablet, has the potential to significantly alleviate pruritus associated with various conditions.